Roberto Gallego-Pinazo
Overview
Explore the profile of Roberto Gallego-Pinazo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
151
Citations
1439
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zarbin M, Weng C, London N, Koh A, Gallego-Pinazo R, Chaudhary V, et al.
Ophthalmol Retina
. 2024 Dec;
PMID: 39733838
No abstract available.
2.
Staurenghi G, Souied E, Iida T, Chow D, Wolf A, Gallego-Pinazo R, et al.
J Vitreoretin Dis
. 2024 Nov;
:24741264241276929.
PMID: 39539820
To review the evolution of terminology describing the classification of lesions in neovascular age-related macular degeneration (nAMD) based on retinal imaging technologies. A review of the current and historical literature...
3.
Puzo M, Calvo-Perez P, Bartol-Puyal F, Sanchez-Monroy J, Martin-Pinardel R, Parrado-Carrillo A, et al.
Eye (Lond)
. 2024 Sep;
38(18):3450-3458.
PMID: 39306616
Objectives: To compare visual outcomes for low vision eyes (LVE) (<35 letters LogMAR or <20/200 Snellen) versus non-low vision eyes (NLVE) (>35 letters LogMAR or >20/200 Snellen) at the time...
4.
Mulyukov Z, Keane P, Sahni J, Liakopoulos S, Hatz K, Ting D, et al.
Ophthalmol Sci
. 2024 Sep;
4(6):100565.
PMID: 39253548
Purpose: To evaluate the performance of a disease activity (DA) model developed to detect DA in participants with neovascular age-related macular degeneration (nAMD). Design: Post hoc analysis. Participants: Patient dataset...
5.
Berni A, Oakley J, Dolz-Marco R, Gallego-Pinazo R, Cimorosi F, Ghilardi A, et al.
Am J Ophthalmol
. 2024 Sep;
269:181-188.
PMID: 39218386
Purpose: This study aims to quantify the volume of intraretinal fluid (IRF), subretinal fluid (SRF), and subretinal pigment epithelium (sub-RPE) fluid in treatment-naïve Type 3 macular neovascularization (MNV) eyes with...
6.
Guymer R, Bailey C, Chaikitmongkol V, Chakravarthy U, Chaudhary V, Finger R, et al.
Ophthalmol Sci
. 2024 Feb;
4(3):100442.
PMID: 38304609
Purpose: To describe the rationale and design of the VOYAGER (NCT05476926) study, which aims to investigate the safety and effectiveness of faricimab and the Port Delivery System with ranibizumab (PDS)...
7.
Vidal-Oliver L, Gallego-Pinazo R, Dolz-Marco R
Transl Vis Sci Technol
. 2024 Jan;
13(1):10.
PMID: 38224331
Purpose: The purpose of this paper was to study the influence of astigmatism in optical coherence tomography angiography (OCTA) images in a quantitative and qualitative analysis. Methods: This was a...
8.
Vidal-Oliver L, Montolio-Marzo E, Gallego-Pinazo R, Dolz-Marco R
Clin Exp Ophthalmol
. 2024 Jan;
52(2):207-219.
PMID: 38214056
Advanced forms of age-related macular degeneration (AMD), characterised by atrophic and neovascular changes, are a leading cause of vision loss in the elderly population worldwide. Prior to the development of...
9.
Ramtohul P, Au A, Kunkler A, Bacci T, Dolz-Marco R, Gallego-Pinazo R, et al.
Retina
. 2023 Dec;
44(4):551-557.
PMID: 38109663
Purpose: To describe the clinical characteristics, multimodal imaging features, and anatomic basis of a distinctive pattern of deep retinal hemorrhages located in the central fovea, a presentation referred to as...
10.
Izquierdo-Serra J, Martin-Pinardel R, Moll-Udina A, Bernal-Morales C, Garay-Aramburu G, Sanchez-Monroy J, et al.
Ophthalmol Retina
. 2023 Nov;
8(4):350-359.
PMID: 37924946
Purpose: To evaluate the influence of macular neovascularization (MNV) lesion type on 12-month clinical outcomes in treatment-naive eyes with neovascular age-related macular degeneration (nAMD) treated with anti-VEGF drugs nationwide. Design:...